Nargesi, Arash A.

Use of wearable devices in individuals with or at risk for cardiovascular disease in the US, 2019 to 2020

Dhingra, L. S., Aminorroaya, A., Oikonomou, E. K., Nargesi, A. A., Wilson, F. P., Krumholz, H. M., & Khera, R. (2023) · JAMA Network Open

Mobile Health and mHealth ApplicationsNon-Invasive Vital Sign Monitoring

Cited by 158

Detection of Left Ventricular Systolic Dysfunction From Electrocardiographic Images

Sangha, V., Nargesi, A. A., Dhingra, L. S., Khunte, A., Mortazavi, B. J., Ribeiro, A. H., Banina, E., Adeola, O., Garg, N., Brandt, C. A., et al. (2023) · Circulation

ECG Monitoring and AnalysisArtificial Intelligence in Healthcare

Cited by 150

Detection of Left Ventricular Systolic Dysfunction from Electrocardiographic Images

Sangha, V., Nargesi, A. A., Dhingra, L. S., Khunte, A., Mortazavi, B. J., Ribeiro, A. H., Banina, E., Adeola, O., Garg, N., Brandt, C. A., et al. (2022) · Circulation

ECG Monitoring and AnalysisArtificial Intelligence in Healthcare

Cited by 150

Contemporary National Patterns of Eligibility and Use of Novel Cardioprotective Antihyperglycemic Agents in Type 2 Diabetes Mellitus

Nargesi, A. A., Jeyashanmugaraja, G. P., Desai, N., Lipska, K., Krumholz, H., & Khera, R. (2021) · Journal of the American Heart Association

Diabetes Treatment and ManagementDiabetes, Cardiovascular Risks, and Lipoproteins

Cited by 61